BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Nasus Pharma Ltd (NSRX) investor events
X-WR-CALNAME:Nasus Pharma Ltd (NSRX) investor events
DESCRIPTION:Earnings calls and investor events for Nasus Pharma Ltd (NSRX)\
 , from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Nasus Pharma Ltd (NSRX)
 \, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:90e0f829-dc38-4ded-b139-1c1fba0e1728@equibles.com
DTSTAMP:20261002T212453Z
DTSTART:20260610T120000Z
DTEND:20260610T130000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Nasus Pharma Ltd (NSRX) Investor Update: Virtual Key Opinion Leader
  Event to Discuss NS002 for the Treatment of Anaphylaxis
DESCRIPTION:Virtual Key Opinion Leader Event to Discuss NS002 for the Treat
 ment of Anaphylaxis\nWebcast: https://lifescievents.com/event/wkp03an/
END:VEVENT
END:VCALENDAR